NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,113 filers reported holding NOVARTIS A G in Q2 2021. The put-call ratio across all filers is 0.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $708,436 | +4.1% | 6,955 | +3.1% | 0.19% | +3.2% |
| Q2 2023 | $680,436 | -2.3% | 6,743 | -10.9% | 0.18% | -5.1% |
| Q1 2023 | $696,624 | +8.3% | 7,572 | +6.8% | 0.20% | +2.1% |
| Q4 2022 | $643,477 | +135.7% | 7,093 | +97.2% | 0.19% | +112.2% |
| Q3 2022 | $273,000 | -11.4% | 3,597 | -1.2% | 0.09% | -10.9% |
| Q2 2022 | $308,000 | -15.2% | 3,640 | -12.0% | 0.10% | -10.6% |
| Q1 2022 | $363,000 | +6.1% | 4,136 | +5.0% | 0.11% | -0.9% |
| Q4 2021 | $342,000 | +25.7% | 3,939 | +18.4% | 0.11% | +14.0% |
| Q3 2021 | $272,000 | -0.7% | 3,326 | +10.7% | 0.10% | -9.1% |
| Q2 2021 | $274,000 | +10.0% | 3,005 | +3.0% | 0.11% | -5.2% |
| Q1 2021 | $249,000 | -0.8% | 2,917 | +9.9% | 0.12% | -6.5% |
| Q4 2020 | $251,000 | +17.3% | 2,655 | +7.9% | 0.12% | -0.8% |
| Q3 2020 | $214,000 | -0.5% | 2,461 | 0.0% | 0.12% | -6.0% |
| Q2 2020 | $215,000 | – | 2,461 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GODSEY & GIBB, INC | 184,900 | $15,121,000 | 6.74% |
| Martin Investment Management, LLC | 289,924 | $23,710,000 | 5.98% |
| Camber Capital Management LP | 2,000,000 | $163,560,000 | 5.04% |
| MANAGED ASSET PORTFOLIOS, LLC | 381,778 | $31,222,000 | 4.76% |
| PROFESSIONAL ADVISORY SERVICES INC | 267,779 | $21,899,000 | 3.22% |
| SCHARF INVESTMENTS, LLC | 1,244,711 | $101,794,000 | 3.21% |
| GARLAND CAPITAL MANAGEMENT INC | 50,755 | $4,151,000 | 2.97% |
| First Fiduciary Investment Counsel, Inc. | 167,378 | $13,688,000 | 2.67% |
| WILKINS INVESTMENT COUNSEL INC | 130,590 | $10,680,000 | 2.61% |
| Lowell Blake & Associates Inc. | 66,309 | $5,423,000 | 2.52% |